AzTrials
AzTrials

Research institution

Medical University Innsbruck Clinical Trials

Studies where Medical University Innsbruck is the lead sponsor: what is enrolling now, by phase, condition and country.

186 registered studies

In numbers

Open to volunteers
40
Active
46
With results posted
6
All registered
186

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 40
  • Mastectomy and Breast Reconstruction, Tissue Expander Based Breast Reconstruction

    Comparison of Mastectomy Expander Trial

    • Recruiting
    • Age: 18 years and older
    • Surgery or procedure

    Expanders are used outside their intended use, due to two following facts: It is possible that expander implantation exceed the "approved" duration of 6 months (maximal 10 months).

    Conditions
    Mastectomy and Breast Reconstruction, Tissue Expander Based Breast Reconstruction, Adjuvant Radiotherapy, Long Term Outcome
    Trial name
    COMMET (NCT07434648)
    Testing
    intervention (unilateral/bilateral), scheduled for (NSME/SSME), indication (breast cancer diagnosis (malignancy) with neoadjuvant chemotherapy or DCIS diagnosis without neoadjuvant chemotherapy
    Where
    Austria
    Volunteers
    80 people
    Sponsor
    Medical University Innsbruck
    Can I take part? COMMET
  • Abdominal Aortic Aneurysm

    Cardiovascular Rehabilitation After Infrarenal Aortic Aneurysm Repair

    • Recruiting
    • Age: 18 years and older

    Evidence about the benefit of cardiovascular rehabilitation (CR) after open or endovascular repair of an infrarenal aortic aneurysm is lacking.

    Trial name
    REHAB-AAA (NCT07690046)
    Testing
    Structured cardiovascular rehabilitation
    Where
    Austria
    Volunteers
    40 people
    Sponsor
    Medical University Innsbruck
    Can I take part? REHAB-AAA
  • Sedation Complication, Sedation During GI Endoscopy

    Safety of Sedation During Interventional Endoscopy

    • Recruiting
    • Age: 18 years and older
    • Observational study

    Sedation is routinely used during interventional endoscopic procedures to improve patient comfort and optimize procedural conditions.

    Trial name
    SCOPE-SAFE (NCT07872657)
    Testing
    Sedation during interventional endoscopy
    Where
    Austria
    Volunteers
    500 people
    Sponsor
    Medical University Innsbruck
    Can I take part? SCOPE-SAFE
  • Alcohol-Associated Hepatitis

    Effect of Alpha-1 Antitrypsin Supplementation on Alcohol-Associated Hepatitis

    • Recruiting
    • Age: 18 years and older
    • Phase 2

    The trial is designed as a prospective, single center, open label, randomized controlled pilot study evaluating the effect of A1AT (Alpha 1 Antitrypsin) on inflammation in patients with severe AAH (alcohol-associated hepatitis).

    Trial name
    EARTH (NCT06582329)
    Testing
    Alfa1 Antitrypsin
    Where
    Austria
    Volunteers
    16 people
    Sponsor
    Medical University Innsbruck
    Can I take part? EARTH
  • Thoracolumbar, Fractures in the Elderly

    Monoaxial vs. Polyaxial Percutaneous Hybrid Stabilization

    • Recruiting
    • Age: 60 years and older
    • Medical device

    Vertebral body fractures in older adults mostly affect the thoracolumbar junction and are challenging to treat due to osteoporosis and other comorbidities.

    Trial name
    NCT07408726
    Testing
    Monoaxial instrumentation - the M.U.S.T. Monoaxial Pedicle Screw Cannulated (Medacta International SA, Switzerland), Polyaxial instrumentation - the M.U.S.T. LT Pedicle Screw System (Medacta International SA, Switzerland)
    Where
    Austria
    Volunteers
    44 people
    Sponsor
    Medical University Innsbruck
  • ST-elevation Myocardial Infarction (STEMI), Clonal Hematopoiesis of Indeterminate Potential (CHIP)

    Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial Infarction

    • Recruiting
    • Age: 18 to 75 years
    • Observational study

    Clonal Hematopoiesis of Indeterminate Potential (CHIP) refers to the age-related expansion of hematopoietic stem cell clones carrying somatic mutations in leukemia-associated driver genes (e.g., DNMT3A, TET2, ASXL1) in the…

    Trial name
    CHIP in STEMI (NCT07615023)
    Testing
    Clonal hematopoiesis assessment and cardiac magnetic resonance imaging
    Where
    Austria
    Volunteers
    350 people, healthy volunteers welcome
    Sponsor
    Medical University Innsbruck
  • Bipolar 1 Disorder, Control Subjects

    Socio-cognitive and Biological Responses to Maltreatment

    • Recruiting
    • Age: 18 to 65 years
    • Observational study

    The study will investigate how a history of emotional childhood maltreatment (CM) is associated with different aspects of psychological (social behaviour, empathy) and biological (brain function and structure, inflammation)…

    Trial name
    NCT07101107
    Where
    Austria
    Volunteers
    160 people, healthy volunteers welcome
    Sponsor
    Medical University Innsbruck
  • Aortic Valve Stenosis and Insufficiency, Coronary Artery Disease(CAD)

    Assessment of Coronary Artery Disease Before Transcatheter Aortic Valve Replacement: A Randomized, Multicenter, Non-Inferiority Trial

    • Recruiting
    • Age: 18 years and older

    The goal of this clinical trial is to determine whether a non-invasive coronary assessment strategy using photon-counting detector computed tomography (PCD-CT) is non-inferior to invasive coronary angiography (ICA) for evaluating…

    Conditions
    Aortic Valve Stenosis and Insufficiency, Coronary Artery Disease(CAD), Transcatheter Aortic Valve Replacement (TAVR)
    Trial name
    TAVR-CT (NCT07107568)
    Testing
    Standard Invasive Coronary Angiography, PCD-CT-Guided Diagnostic Strategy
    Where
    2 sites in Austria
    Volunteers
    700 people
    Sponsor
    Medical University Innsbruck
    Can I take part? TAVR-CT
  • ST Elevation Myocardial Infarction, C-Reactive Protein

    CRP Apheresis in STEMI

    • Recruiting
    • Age: 18 to 85 years
    • Medical device

    Background: In patients with acute ST-elevation myocardial infarction (STEMI), the amount of infarcted myocardium (infarct size) is known to be a major predictor for adverse remodeling and recurrent adverse cardiovascular events.

    Conditions
    ST Elevation Myocardial Infarction, C-Reactive Protein, Apheresis, Myocardial Injury
    Trial name
    NCT04939805
    Testing
    Selective CRP apheresis using the PentraSorb®-CRP system
    Where
    5 sites in Austria, Germany
    Volunteers
    202 people
    Sponsor
    Medical University Innsbruck
  • Healthy Control Subjects, Schizophrenia Diagnosis

    Understanding Lifespan Trajectories of Social Cognition, Brain Microstructure and Iron Dysregulation in Schizophrenia

    • Recruiting
    • Age: 18 to 70 years
    • Observational study

    This study aims to better understand how schizophrenia may affect social thinking, emotion regulation, brain function, and biological processes over time. Two groups will take part in the study: 1.

    Trial name
    NCT07856381
    Where
    Austria
    Volunteers
    180 people, healthy volunteers welcome
    Sponsor
    Medical University Innsbruck

Completed, with results posted

All 5
  • Parkinson's Disease, Neurogenic Orthostatic Hypotension in Parkinson's Disease

    Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)

    • Completed
    • Age: 40 to 90 years
    • Phase 2
    • Medical device
    • Results posted

    The purpose of the present study is to determine whether the use of an abdominal binder is effective in the non-pharmacological management of orthostatic hypotension in patients suffering from Parkinson's disease

    Trial name
    ABOHP (NCT01971008)
    Testing
    Elastic abdominal binder
    Where
    Austria
    Volunteers
    15 people
    Sponsor
    Medical University Innsbruck
    Can I take part? ABOHP
  • SARS-CoV-2, COVID-19

    Stopping ACE-inhibitors in COVID-19

    • Completed
    • Age: 18 years and older
    • Phase 4
    • Results posted

    ACEI-COVID-19 is a multicenter, randomized trial testing the hypothesis that stopping/replacing chronic treatment with ACE-inhibitors (ACEI) or angiotensin receptor blockers (ARB) improves outcomes in symptomatic…

    Trial name
    ACEI-COVID (NCT04353596)
    Testing
    ACE inhibitor, angiotensin receptor blocker
    Where
    31 sites in Austria, Germany
    Volunteers
    216 people
    Sponsor
    Medical University Innsbruck
    Can I take part? ACEI-COVID
  • Parkinson Disease

    Nabilone for Non-motor Symptoms in Parkinson's Disease

    • Completed
    • Age: 30 to 100 years
    • Phase 3
    • Results posted

    This is an open-label extension study for participants of the randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal NMS-Nab Study, assessing the long-term safety and efficacy of…

    Trial name
    NMS-Nab2 (NCT03773796)
    Testing
    Nabilone 0.25 mg
    Where
    Austria
    Volunteers
    22 people
    Sponsor
    Medical University Innsbruck
    Can I take part? NMS-Nab2
  • Parkinson Disease

    Nabilone for Non-motor Symptoms in Parkinson's Disease

    • Completed
    • Age: 30 to 100 years
    • Phase 2
    • Results posted

    This is a randomized placebo-controlled, double-blind, parallel-group, enriched enrollment randomized withdrawal study assessing the efficacy and safety of nabilone for non-motor symptoms in patients with Parkinson´s Disease.

    Trial name
    NMS-Nab (NCT03769896)
    Testing
    Nabilone 0.25 mg
    Where
    Austria
    Volunteers
    48 people
    Sponsor
    Medical University Innsbruck
    Can I take part? NMS-Nab
  • Hallux Valgus

    Continuous Wound Infiltration After Hallux Valgus Surgery

    • Completed
    • Age: 18 years and older
    • Phase 4
    • Medical device
    • Results posted

    The aim of this study is to investigate the effect of continuous wound infiltration with ropivacaine in comparison to standard pain management after elective distal metatarsal osteotomy for postoperative pain control.

    Trial name
    CWI-HVS (NCT02182999)
    Testing
    Wound infiltration catheter, NaCl 0.9%, Ropivacaine 0.2%
    Where
    Austria
    Volunteers
    50 people
    Sponsor
    Medical University Innsbruck
    Can I take part? CWI-HVS

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in